INTRODUCTION
Nevoid basal cell carcinoma syndrome (NBCCS; MIM 109400), also known as Gorlin syndrome or basal cell nevus syndrome, is a rare autosomal dominant disorder. 1, 2 NBCCS is characterized by developmental defects, such as calcification of the falx celebri, multiple nevi, palmar and plantar pits and skeletal abnormality. 2, 3 It is also known to predispose individuals to cancers, including basal cell carcinoma (BCC), keratocystic odontogenic tumor (KCOT), medulloblastoma (MB), rhabdomyosarcoma and benign tumors, such as ovarian and cardiac fibroma. The hedgehog (Hh) receptor, Patched1 (PTCH1), the human homolog of Drosophila segment polarity gene patched, which is located at chromosome 9q22.3, has been identified as a gene responsible for NBCCS. [4] [5] [6] PTCH1 spans 34 kb and consists of at least 23 exons. It encodes a 1447 amino acid protein with 12 potential hydrophobic membrane-spanning domains, intracellular amino-and carboxy-terminal regions and two large hydrophilic extracellular loops in which the Hh protein binds. 7, 8 To date, nearly 300 mutations have been identified in PTCH1. 9 Among them, more than 150 germline mutations have been reported in NBCCS patients, including nonsense and missense mutations, insertions or deletions and splice site mutations. In addition to NBCCS cases, PTCH1 mutations have also been reported in many malignant neoplasms, such as sporadic BCC, KCOT, MB, primitive neuroectodermal tumor, breast cancer, colon cancer and meningioma. 10, 11 Nearly 90% of sporadic BCCs, 12 10-20% of sporadic MBs 13 and approximately 30% of sporadic KCOTs 14 carry PTCH1 loss-of-function mutations. KCOT and BCC are two major tumors that characteristically develop in NBCCS patients. However, MB and other cancers are rarely seen. It is currently unclear whether the locations of mutations within PTCH1 are relevant to clinical manifestation in NBCCS. However, identification of mutations is very helpful for genetic counseling and for giving clinical advice because patients with mutations are at high risk of NBCCS.
Herein, we identified PTCH1 mutations in two familial and three sporadic NBCCS cases whose first symptoms were KCOTs. One sporadic patient with a splice-site mutation had a history of MB. This is the first report of a molecularly defined Japanese NBCCS patient with MB. In addition, we have analyzed all data from molecularly defined Japanese NBCCS cases. Comparison among ethnically different NBCCS patients will be discussed.
MATERIALS AND METHODS
All analyses described below were approved by the Medical Ethics Board of Hyogo College of Medicine (No. 108) and Tokuyama Central Hospital. The patients and their parents gave informed consent to participate in this study.
Patients
We studied seven Japanese patients from five unrelated families who visited Hyogo College of Medicine or Tokuyama Central Hospital, Japan (Figure 1 ). Family 1. An 11-year-old Japanese boy. He was born with congenital cleft lip and palate (Figure 2a) , and was treated at the Department of Oral and Maxillofacial Surgery, Hyogo College of Medicine in 1996. During a series of treatments, MB was found (Figure 2c ), and surgical resection and chemotherapy were performed. At the age of 11 years, he noticed pus discharge from the right second premolar of the mandible. Panoramic radiography and computed tomography revealed multiple cystic radiolucent areas with impacted teeth (Figure 2b ). Moreover, ectopic calcification of the falx cerebri was also detected by computed tomography (Figure 2d ). Broad forehead, highly arched eyebrows, ocular hypertelorism and palmar pits were present in this patient. Surgical resection of jaw cysts was performed. Histopathological diagnoses identified all lesions as KCOTs (Figure 2e) . Histopathological diagnoses identified all lesions as KCOTs. BCCs were found in his skin at the age of 40 years and were surgically removed. He showed palmar and plantar pits, and calcification of the falx cerebri.
Family 4. The proband was a 9-year-old Japanese girl who showed multiple jaw cysts on panoramic radiography. She underwent an operation in the Division of Oral Surgery, Tokuyama Central Hospital. Histopathological diagnoses identified all lesions as KCOTs. She showed palmar and plantar pits and calcification of the falx cerebri. Her father, a 38-year-old Japanese, showed multiple jaw cysts, palmar and plantar pits, calcification of the falx cerebri and macrocephaly. Her mother was healthy.
Family 5. The proband was a 12-year-old Japanese girl who showed multiple jaw cysts on panoramic radiography. She underwent an operation in the Division of Oral Surgery, Tokuyama Central Hospital. Histopathological diagnoses identified all lesions as KCOTs. She showed palmar and plantar pits and calcification of the falx cerebri. Her mother, a 44-year-old Japanese, had KCOTs and showed calcification of the falx cerebri. Her father was healthy.
These cases were diagnosed as having NBCCS by the clinical criteria of Kimonis et al. 3 (Table 1) .
DNA isolation, amplification and sequencing analysis
Genomic DNA from blood samples was extracted using the QIAamp DNA Blood Midi Kit (Qiagen, Hilden, Germany). All coding exons and intron-exon boundaries were amplified by PCR and sequenced. The primers used in this study have been previously described. 15 PCR was carried out in a total reaction volume of 50 ml, containing 100 ng genomic DNA, 1 U Primer STAR HS DNA polymerase (TaKaRa, Ohtsu, Japan), 200 mM dNTPs and 0.2 mM of each primer. Amplification was carried out for 40 cycles of 98 1C for 10 s, 55 1C for 5 s and 72 1C for 60 s. Amplified products were purified using the MinElute PCR Purification Kit (Qiagen). Sequencing was performed using a BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) and a 3130xl Genetic Analyzer (Applied Biosystems), according to the manufacturer's instructions.
For analysis of aberrant splicing, total RNA was extracted from cell line, ImNBCCS-KCOT (KCOT-derived cell line from patient NS11: Noguchi K, manuscript in preparation), using the QIAamp RNA Blood Mini Kit (Qiagen) and subjected to RT-PCR using a Cells-to-cDNA II Kit (Applied Biosystems). The forward primer for exon 3 was 5¢-TTATACTCGCCAGAAGATTGGAGA AGA-3¢, and the reverse primer for exon 6 was 5¢-GTCCATGTAACCATGACCA ACCTCAG-3¢. Amplified products were gel purified and sequenced as described above.
Data analysis of Japanese NBCCS patients
Data from molecularly defined Japanese NBCCS patients were obtained from published papers. Suspected NBCCS patients, who had not been molecularly defined, were excluded in this analysis. All patients were analyzed based on major diagnostic criteria, such as BCC, KCOT, palmar and plantar pits, calcification of the falx cerebri and various tumors.
RESULTS
Sequencing analysis revealed PTCH1 mutations in all NBCCS patients ( Figure 1 , Table 2 ). The mutations in families 1, 2, 4 and 5 were novel, and the mutation in family 3 was previously reported in a KCOT sample from a Brazilian NBCCS patient. 16 We found a mutation at a PTCH1 splice donor site in patient NS11, therefore, we analyzed PTCH1 mRNA using cells derived from a KCOT from NS11. Sequence analysis of DNA derived from KCOT cells and peripheral blood of NS11 showed identical patterns. Therefore, a cell line was derived from the NS11 KCOT and neither additional mutations nor evidence of loss of heterozygosity in PTCH1 were found in these cells. To analyze the splicing events, total RNA was extracted from NS11-derived cells and RT-PCR was performed using a pair of primers located in exon 3 and exon 6 (Figure 3d ). RT-PCR produced two bands (Figure 3a ), which were sequenced separately (Figures 3b  and c) . The short transcript, transcript 1, consisted of wild-type sequences (Figure 3b ). The longer fragment revealed that this mutation activated a cryptic splice site in intron 3, resulting in a 37 bp insertion of intronic sequence into the mRNA (Figures 3c  and d) . This insertion induced a frame shift and termination after 58 additional amino acids. This additional sequence did not show obvious homology to any other known protein. 
Minor symptoms
Macrocephaly (after correction for height)
In families 2 and 3, the mutations created stop codons (Table 2 ). In families 4 and 5, the mutations caused frame shifts, resulting in stop codons after 11 and 15 amino acids, respectively.
The spectrum of PTCH1 mutations in Japanese NBCCS patients was analyzed based on the literature. 15, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Table 3 summarizes the spectrum of PTCH1 mutations and phenotypes of Japanese NBCCS patients. Overall 56 subjects who fulfilled the criteria for NBCCS were analyzed. There were 31 men and 25 women, ranging in age from 0 to 71 years (average 26.3 years). Mutations were scattered throughout the entire gene. Therefore, there is no mutational hot spot and also no founder effect for NBCCS in Japan. Patients with KCOTs represented 87.3% (48/55) of patients. Pits were observed in 43/53 (81.1%) of cases. Calcification of the falx cerebri was seen in 39/50 (78.0%) of cases. BCC occurred in 14/56 (25.0%) of cases. 8/15 (53.3%) of cases over 40 years of age had developed a BCC. Other cancers were reported in two cases, one MB (our study) and one meningioma.
DISCUSSION
We analyzed two familial and three sporadic Japanese NBCCS patients, and identified germline PTCH1 mutations in all patients: one splice site mutation (c.584+2T4G), two nonsense mutations (c.3058C4T and c.2760C4A), one 1 bp insertion (c.2712_2713insA) and one 1 bp deletion (c.980Gdel). All mutations induce premature A point mutation in intron 3 (c.584+2T4G) of PTCH1 was detected in patient NS11. RT-PCR analysis revealed that at least two transcripts were generated from this region (Figure 3a) . Sequence analysis indicated that the short transcript, transcript 1, consisted of wild-type sequences (Figure 3b ), whereas the long transcript, transcript 2, consisted of a mutated sequence (Figure 3c ). These data suggested that the long transcript was not the product of a normal alternative splicing event and that c.584+2T4G generated a cryptic splice site in intron 3, resulting in the insertion of 37 extra bases into the mRNA. This activated splice site conformed to the authentic GT-AG rule. Interestingly, a very similar, but not identical mutation, which generates an identical 37-bp insertion, has been reported. 21 In that case, the mutation, c.584G4A, was in the exon, but affected the splice donor sequence and induced aberrant splicing. The cryptic splice site generated by c.584G4A was identical to that generated by c.584+2T4G.
Patient NS11 showed a complicated cleft lip and palate with MB ( Figure 2 ). In NBCCS, the morbidity rate of cleft lip and palate is approximately 5%, which is the same as that of MB. 3, 29, 30 Therefore, this is a very rare case. His clinical manifestation was severe, but none of his family exhibited NBCCS symptoms; therefore, this mutation seems to be de novo. This is the first report of a Japanese NBCCS patient with MB. PTCH1 mutations in sporadic MBs are scattered throughout the entire gene, 9 similar to that of NBCCS cases, indicating no correlation between the position of the mutations and the observed phenotype. His KCOT-derived cells showed neither extra mutations nor evidence of loss of heterozygosity, at least in the PTCH1-coding region. Therefore, additional alterations, in addition to that in observed PTCH1, must be involved in this KCOT formation.
Clinical manifestations in NBCCS individuals have been reported in different ethnic groups. 3, [29] [30] [31] [32] [33] Comparison of the frequencies of major phenotypes in NBCCS, such as BCCs, KCOTs, palmar or plantar pits and calcification of the falx cerebri are listed in Table 4 . Obvious differences were found in the onset of BCCs. In Caucasian NBCCS patients, more than 70% (over the age of 20 years) or 90% (over the age of 40 years) of patients developed BCC. 3, 29, 30 Kimonis et al. 3 estimated that the probability of developing BCCs was approximately 90% in Caucasians and 40% in African-Americans by the age of 35 years. In contrast, BCCs developed in only 38% (over the age of 20 years) and 53% (over the age of 40 years) of Japanese patients. On the other hand, KCOT was found in more than 80% (over the age of 20 years) in all populations. These data suggested that allelic loss of PTCH1 has different consequences in different genetic backgrounds and in different tissues. The analysis of molecules involved in these differences will help to prevent or delay the onset of BCCs. 
